Tag: U.S. Supreme Court

Supreme Court Issues Landmark Rulings in Two Patent Cases, Further Admonishes Federal Circuit and Lowers the Bar for Patent Challenges

This post, authored by Kirk Watkins and Christy Dupriest, was first published here on June 3 as a Womble Carlyle Case Alert. In two decisions with immediate and potentially far-reaching consequences, the Supreme Court yesterday unanimously overturned two Federal Circuit decisions.  These decisions continue the trend of the Roberts […]

Supreme Court Will Review Eleventh Circuit’s Decision in Andro-Gel® “Pay for Delay” Case

The Supreme Court acted with faster-than-expected speed, granting a petition to review an Eleventh Circuit decision upholding a “pay for delay” agreement (also called a “reverse payment” agreement),[1] which involves the patented drug AndroGel®, against an antitrust attack.  As reported in Bloomberg.com, “Companies have struck more than 100 […]

Watson Pharmaceuticals Responds to FTC’s Petition for Supreme Court Review of "Pay for Delay" Case; 31 States File Amici Curiae Brief

In our July 23 post, we covered the Eleventh Circuit’s denial of a petition for a rehearing filed by the Federal Trade Commission (“FTC”), in which the Eleventh Circuit let stand its earlier rejection of the FTC’s challenge that a “pay for delay” agreement (also called a “reverse payment” agreement)[1] violated antitrust laws. In […]

UPDATE: FTC Seeks Supreme Court Review of 11th Circuit’s Decision in "Pay for Delay" Case

In a July 23 entry, we summarized the Eleventh Circuit’s ruling upholding a “pay for delay” agreement between pharmaceutical companies to settle patent litigation.[1]  That agreement had been attacked by the Federal Trade Commission (“FTC”) as violating antitrust laws. We characterized conflicting approaches between federal appellate courts on how […]